- Country: USA
- Summary: Terumo BCT Spectra Optia Apheresis Systems Preventative Maintenance Services
- UST Ref No: 119637860
- Deadline: 02 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 25-007126
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Terumo BCT Spectra Optia Apheresis Systems Preventative Maintenance Services
Product Service Code: J066-Maint/repair/rebuild Of Equipment- Instruments and
Laboratory Equipment
NAICS Code: 811210-Electronic and Precision Equipment Repair and Maintenance
Place of Performance: Bethesda, MD 20892
POTS: 25-007126
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Department of Transfusion Medicine (DTM), Center for Cellular Engineering intends to award a base year with two-years options firm-fixed price purchase order to Terumo BCT, Inc. on a sole source basis located at 10811 W. Collins Avenue, in Lakewood, Colorado 80215-4440 to perform preventative maintenance services.
The Department of Transfusion Medicine, Center for Cellular Engineering has a requirement for preventative maintenance services on two (2) Spectra Optia Apheresis Systems. The Department of Transfusion Medicine, Blood Services Section is a unique blood center which collects blood and blood components from healthy donors for patients participating in many protocols. However, blood and blood products are also withdrawn from patients when prescribed by a physician, which may have a therapeutic benefit to treat medical conditions. The Food and Drug Administration (FDA) regulates equipment that is used to manufacture cell-based therapies in accordance with the following codes of Federal Regulations 21 CFR 210,211,600 and 1271. 21 CFR 211.67 which state that all equipment shall be maintained as appropriate. Terumo BCT is the sole manufacture of its equipment and proprietary software and the only approved vendor by the Quality Assurance Team to perform these services.
This acquisition is being conducted using policies unique... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTerumo BCT Spectra Optia Apheresis Systems Preventative Maintenance Services - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Terumo BCT Spectra Optia Apheresis Systems Preventative Maintenance Services. This tender is published on USARFP under UST Ref No: 119637860 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-02.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
